Feb 20, 2020
Recordati Rare Diseases, Inc. Announces Transfer of U.S. Marketing Rights to SIGNIFOR® (pasireotide) Injection and SIGNIFOR LAR® (pasireotide) for Injectable Suspension
Jan 30, 2020
Rani Therapeutics Announces Positive Phase I Study Results of Oral Octreotide using RaniPill(TM)
Jan 07, 2020
Ipsen Announces the Availability of the Newly Designed Delivery System for Somatuline® Autogel® (lanreotide injection)
Dec 12, 2019
Global Somatostatin Analogs Industry Outlook, 2019-2026 - Pasireotide Estimated to Be the Fastest Growing Segment Over the Forecast Period
Dec 04, 2019
Study Finds Key Brain Region Smaller in Birth Control Pill Users
Nov 07, 2019
Global Neuroendocrine Tumors (NETs) Market Report 2019
Nov 07, 2019
CASI Pharmaceuticals Enters Exclusive China Distribution License Agreement For Octreotide Long Acting Injectable (LAI) Microsphere For Neuroendocrine Cancers And Acromegaly
Aug 19, 2019
Acromegaly Treatment Market Size Worth $2.10 Billion by 2025: Grand View Research, Inc.
Jun 20, 2019
Camurus Receives IND Acceptance From the FDA to Enter Phase 3 with CAM2029 for Treatment of Acromegaly
Jun 03, 2019
NET (Neuroendocrine Tumor) Treatment Market Size Worth $3.33 Billion By 2025 | CAGR 10.4%: Grand View Research, Inc.
Feb 20, 2019
Sosei Heptares Starts New Clinical Development Program
Dec 12, 2018
Entrinsic Health Solutions and Markey Cancer Center Launch Phase II Study for Neuroendocrine Tumor Patients with Quality of Life-Limiting Diarrhea
Nov 05, 2018
Exclusive Forecast Study Observes Cushings Syndrome and Acromegaly Treatment Market to Incur Value Growth at 9.3% CAGR During 2018 - 2026 Persistence Market Research
Nov 01, 2018
The Courage to Share Our Story: The Power of Building Acromegaly Awareness
Oct 16, 2018
Health Canada approves XERMELO(TM) (telotristat ethyl) for the treatment of adult patients suffering from refractory carcinoid syndrome diarrhea(1)
Sep 27, 2018
Acromegaly Patients Shed Light on their Disease
Sep 14, 2018
New Study Finds Unexpected Link Between Immune Cells and Male/Female Differences
Jun 01, 2018
Acromegaly Pipeline Analysis 2018: 10 Drugs Currently in Different Phases of Development
May 24, 2018
ATL1103 Phase II trial results published in the European Journal of Endocrinology
Mar 14, 2018
Global Acromegaly and Gigantism Drugs Market 2018-2022: Growing Popularity of Drugs Over Surgeries & Focus on Long-Acting Novel Formulations